Alterity Therapeutics (PRNAD) EBT (2009 - 2019)

Alterity Therapeutics (PRNAD) has reported EBT for 5 consecutive years, with -$3.9 million the latest figure, recorded in Q4 2019.

• In Q4 2019, EBT fell 0.58% year-over-year to -$3.9 million; the TTM figure through Dec 2019 stood at -$13.2 million (down 502.2% YoY), while the FY2025 annual figure was -$7.7 million, up 38.47% from the prior year.
• EBT came in at -$3.9 million for Q4 2019 at Alterity Therapeutics, down from -$3.8 million in the prior quarter.
• The five-year high for EBT was -$2.7 million in Q4 2016, with the low at -$3.9 million in Q4 2019.
• Average EBT over 4 years is -$3.3 million, with a median of -$3.3 million recorded in 2017.
• Across the five-year window, EBT plunged 37.71% in 2018 and slipped 0.58% in 2019, its largest moves.
• Year by year, EBT stood at -$2.7 million in 2016, then retreated by 1.55% to -$2.8 million in 2017, then sank by 37.71% to -$3.8 million in 2018, then retreated by 0.58% to -$3.9 million in 2019.
• According to Business Quant data, EBT over the past three periods registered -$3.9 million, -$3.8 million, and -$2.8 million for Q4 2019, Q4 2018, and Q4 2017 respectively.